🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to assess the safety and efficacy of multiple inter...
Status
Completed
Location
Alabama Liver & Digestive Specialists
Start Date
2011-09
Trial ID
NCT01435044
Treatments Being Tested
Two Groups of Genotype 4 HCV Patients will participate through open-label r...
Status
Completed
Location
Egyptian Liver Hospital
Start Date
2015-07
Trial ID
NCT02483156
Open-label, partially-randomized plasma and liver sampling study to assess ...
Status
Completed
Location
Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Start Date
2017-01
Trial ID
NCT02938013
Treatments Being Tested
This primary objectives of the study are to evaluate the safety, tolerabili...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2015-02-17
Trial ID
NCT02378935
This project is a randomized trial of two strategies to treat persons with ...
Status
Completed
Location
Substance Use Research Unit
Start Date
2015-12
Trial ID
NCT02609893
Epclusa® is a pan-genotypic, once-daily tablet for the treatment of chronic...
Status
Completed
Location
Radboud university medical Center
Start Date
2018-08-01
Trial ID
NCT03513393
Treatments Being Tested
This study will evaluate the antiviral efficacy, safety, and tolerability o...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02413593
A total of 201 participants with chronic HCV GT4 infection were allocated i...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT04385407
Treatments Being Tested
This open-label study will evaluate the safety and efficacy of co-formulate...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02399345
Treatments Being Tested
The primary objectives of this study are to evaluate the antiviral efficacy...
Status
Completed
Location
Multiple Locations
Start Date
2016-04-12
Trial ID
NCT02738333